Quarterly report pursuant to Section 13 or 15(d)

ORGANIZATION AND BUSINESS (Details)

v3.22.2.2
ORGANIZATION AND BUSINESS (Details)
$ in Millions
9 Months Ended
Sep. 30, 2022
USD ($)
Facility
Product
Organization and Business [Abstract]  
Number of plasma collection facilities under approval and development 10
Number of FDA-licensed plasma collection facilities 7
Number of additional plasma collections centers in operation and collection of plasma 2
Number of FDA approved product | Product 3
Working capital | $ $ 179.7
Cash and cash equivalents | $ $ 34.9